REAL-WORLD EVIDENCE & DIAGNOSTICS IN CANCER: FILLING THE GAPS IN ONCOLOGY TREATMENT
Real-world evidence (RWE) is used in an exponential way to guide payment decisions and access systems for patients and help clinical decision-making in conditions such as cancer characterized by heterogeneous patient groups and different care routes. In the world of cancer diagnostics, RWE draws from a range of sources, including electronic health reports, customer data, payer claims databases, patient registries, and others, allowing innovators to explain how a product can work over some time within a larger, more representative population. This approach to evidence generation is of great concern to payers, as they increasingly rely on RWE to make decisions on coverage and reimbursement. https://www.delveinsight.com/whitepaper-newsletter/real-world-evidence-diagnostics-in-cancer
34 views • 2 slides